These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2687617

  • 1. [Management of the neutropenic and febrile immunocompromised host].
    Barsanti AC, Tartas N.
    Medicina (B Aires); 1988; 48(6):679-94. PubMed ID: 2687617
    [No Abstract] [Full Text] [Related]

  • 2. Empiric antibiotic therapy in the neutropenic patient.
    Boogaerts M.
    Br J Clin Pract Suppl; 1988 Feb; 57():85-90. PubMed ID: 3140885
    [No Abstract] [Full Text] [Related]

  • 3. [Evaluation of antibiotics in febrile neutropenic patients with cancer].
    Villegas JB, Gavilán MG.
    Rev Esp Quimioter; 1999 Jun; 12(2):104-6. PubMed ID: 10562669
    [No Abstract] [Full Text] [Related]

  • 4. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K.
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [Abstract] [Full Text] [Related]

  • 5. Response rates to a staged antibiotic regimen in febrile neutropenic patients.
    Barnes RA, Rogers TR.
    J Antimicrob Chemother; 1988 Nov; 22(5):759-63. PubMed ID: 3209532
    [Abstract] [Full Text] [Related]

  • 6. Empirical antibiotics for febrile neutropenic cancer patients.
    Hathorn JW.
    Eur J Cancer Clin Oncol; 1989 Nov; 25 Suppl 2():S43-51. PubMed ID: 2693109
    [Abstract] [Full Text] [Related]

  • 7. Fungal infection and fever of unknown origin in neutropenic patients.
    Bodey GP.
    Am J Med; 1986 May 30; 80(5C):112-9. PubMed ID: 3717185
    [No Abstract] [Full Text] [Related]

  • 8. [Nosocomial infections in neutropenic patients].
    Cordonnier C.
    Rev Prat; 1989 May 25; 39(16):1403-8. PubMed ID: 2740792
    [Abstract] [Full Text] [Related]

  • 9. Controversies in the management of febrile neutropenic cancer patients.
    Rubin M, Hathorn JW, Pizzo PA.
    Cancer Invest; 1988 May 25; 6(2):167-84. PubMed ID: 3132310
    [No Abstract] [Full Text] [Related]

  • 10. Antimicrobial prophylaxis for infection in neutropenic patients.
    Bodey GP.
    Curr Clin Top Infect Dis; 1988 May 25; 9():1-43. PubMed ID: 3077285
    [No Abstract] [Full Text] [Related]

  • 11. Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever.
    Jun HX, Zhixiang S, Chun W, Reksodiputro AH, Ranuhardy D, Tamura K, Matsumoto T, Lee DG, Purushotaman SV, Lim V, Ahmed A, Hussain Y, Chua M, Ong A, Liu CY, Hsueh PR, Lin SF, Liu YC, Suwangool P, Jootar S, Picazo JJ.
    Int J Antimicrob Agents; 2005 Dec 25; 26 Suppl 2():S128-32; discussion S133-40. PubMed ID: 16253480
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical and epidemiological features of infections in the neutropenic patient].
    Viscoli C, Castagnola E.
    Haematologica; 1989 Oct 25; 74(5 Suppl):287-96. PubMed ID: 2512215
    [No Abstract] [Full Text] [Related]

  • 13. European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
    Croydon E, Weerts D.
    Chemioterapia; 1987 Jun 25; 6(2 Suppl):405-7. PubMed ID: 3334585
    [No Abstract] [Full Text] [Related]

  • 14. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J.
    J Antimicrob Chemother; 2009 May 25; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [Abstract] [Full Text] [Related]

  • 15. [Diagnosis and treatment of infection in the support of the neutropenic patient].
    Rafecas FJ, Sanz MA, Martín-Aragones G, Martínez JA, Sayas MJ, Marty ML.
    Sangre (Barc); 1985 May 25; 30(4-B):501-14. PubMed ID: 4081964
    [No Abstract] [Full Text] [Related]

  • 16. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years.
    Bodey GP.
    J Antimicrob Chemother; 2009 May 25; 63 Suppl 1():i3-13. PubMed ID: 19372179
    [Abstract] [Full Text] [Related]

  • 17. Management of infections in immunocompromised cancer patients.
    Bajetta E, Gasparini G, Monfardini S, Volonterio A, Buzzoni R, Shinde S.
    Haematologica; 1984 May 25; 69(5):576-97. PubMed ID: 6437936
    [No Abstract] [Full Text] [Related]

  • 18. Neutropenia and fever.
    Hughes WT.
    Pediatr Infect Dis; 1983 May 25; 2(3 Suppl):S14-7. PubMed ID: 6866796
    [No Abstract] [Full Text] [Related]

  • 19. A study of antibiotic therapy in fever of unknown origin in neutropenic cancer patients.
    Björnsson S, Preisler H, Henderson ES.
    Med Pediatr Oncol; 1977 May 25; 3(4):379-85. PubMed ID: 337094
    [Abstract] [Full Text] [Related]

  • 20. Antibiotic choice in the neutropenic patient.
    Winslow DL.
    Del Med J; 1984 Jul 25; 56(7):413-5. PubMed ID: 6479386
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.